Use The Trademark Exclusively Headlines
7 Social Networking Apps for When Facebook Jumps the Shark
Facebook fever is everywhere. If you need to escape, here are seven social networking apps you can use to fill the void.
Read more...
Santarus Announces Presentation of UCERIS Phase III Extended Use Data at Digestive Disease Week Meeting
Santarus, Inc. today announced that safety and efficacy data from a Phase III, double-blind, multicenter, placebo-controlled 12 month extended use study with the inv
Read more...
Eutropics Pharmaceuticals Receives U.S. Patent for Novel Diagnostic Method
CAMBRIDGE, Mass., May 8, 2012 /PRNewswire/ -- Eutropics Pharmaceuticals today announced that the United States Patent and Trademark Office has issued patent number 8,168,755 entitled, "Antibodies ...
Read more...
United States Patent and Trademark Office Issues Broader Claims for ArunA Biomedical’s Exclusively Licensed Stem Cell ...
Aruna Biomedical, Inc., the exclusive worldwide commercial licensee of stem cell technology developed at the University of Georgia (UGA), announced today that the US Patent and Trademark Office will issue a new patent mid-month that enlarges the scope of the licensed patent portfolio to include primate pluripotent stem cells.Athens, GA (PRWEB) May 11, 2012 ArunA Biomedical first announced its ...
Read more...
Press Release
Santarus Inc. Posted on:18 May 12 Santarus, Inc . (NASDAQ: SNTS) today announced that safety and efficacy data from a Phase III, double-blind, multicenter, placebo-controlled 12 month extended use study with the investigational drug UCERIS™ (budesonide) 6 mg tablets (previously referred to as budesonide MMX®) will be featured in four poster presentations at the Digestive Disease Week (DDW® ...
Read more...
|